viernes, 18 de mayo de 2018

A clinical trial saved my life

MD Anderson Cancer Center
I'm happy to be a trailblazer

By the time I got to The University of Texas MD Anderson Cancer Center, I had already been through the wringer.
I'd had my spleen removed, spent over a month in the hospital, and gone through multiple rounds of high-dose chemo, all before being diagnosed with diffuse large B-cell lymphoma. At MD Anderson, I underwent an autologous stem cell transplant, which unfortunately wasn't successful.
MD Anderson was about to launch a CAR T-cell lymphoma clinical trial, and Sattva Neelapu, M.D., co-leader of the multi-center study, had just one spot left. I was excited to learn that I qualified.
Before I was on a clinical trial, I felt sorry for patients participating in them. I considered clinical trials a last-ditch effort, and I felt they marked a really low point in someone's life.
So, when I was faced with the possibility of being on one myself, my reaction wasn't at all what I expected. I felt grateful to have another option — a really viable one that my doctors were excited about. And for the first time in a long time, I actually felt hopeful.
I'm happy to report that the trial worked, and I'm now in remission. Even better, CAR T-cell therapy has since been approved by the FDA for treating lymphoma based on the results of the MD Anderson-led trial.
Knowing that I was a trailblazer in this area makes me feel so proud. Clinical trials are the future of medicine.
MD Anderson must have support from friends like you to continue funding groundbreaking research — like the clinical trial that saved my life.
Please give now in honor of National Cancer Research Month. Help blaze another trail.
Thank you,
Emily Dumler
Give now

No hay comentarios:

Publicar un comentario